SMAD9 — SMAD Family Member 9
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">SMAD9</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SMAD9</td></tr>
<tr><td><strong>Full Name</strong></td><td>SMAD Family Member 9 (SMAD8)</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>13q14.11</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[4094](https://www.ncbi.nlm.nih.gov/gene/4094)</td></tr>
<tr><td><strong>OMIM</strong></td><td>603295</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000120798</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[O15118](https://www.uniprot.org/uniprot/O15118)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>467 amino acids</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Transcription factor, R-SMAD</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Primary Pulmonary Hypertension, Hereditary Hemorrhagic Telangiectasia</td></tr>
</table>
</div>
Overview
SMAD9 (also known as SMAD8) is a receptor-regulated SMAD (R-SMAD) transcription factor that primarily mediates bone morphogenetic protein (BMP) signaling. As a member of the SMAD family, SMAD9 plays crucial roles in transmitting signals from cell surface BMP receptors to the nucleus, where it regulates the transcription of target genes. Unlike SMAD1 and SMAD5, which also mediate BMP signaling, SMAD9 has distinct expression patterns and functional properties that make it particularly important in specific biological contexts [1][3].
In the nervous system, SMAD9 is involved in regulating neural stem cell biology, neurogenesis, neuronal differentiation, synaptic plasticity, and glial cell function. Dysregulated SMAD9 signaling has been implicated in the pathogenesis of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative conditions [5][6]. The protein also plays important roles in vascular development, which is relevant to understanding the vascular components of neurodegenerative diseases.
The gene is located on chromosome 13q14.11, encodes a protein of 467 amino acids with a molecular weight of approximately 52 kDa, and is widely expressed in various tissues including brain, lung, heart, and skeletal muscle.
Discovery and Nomenclature
SMAD9 was originally identified as SMAD8 based on its sequence homology to other SMAD family members. Subsequent studies revealed its functional properties as a BMP-specific SMAD, leading to its renaming as SMAD9. The SMAD family name derives from the homology to the Drosophila gene "Mothers against decapentaplegic" (MAD) and the related vertebrate genes [1].
Initial characterization of SMAD9 demonstrated that it functions similarly to SMAD1 and SMAD5 as a BMP-specific SMAD, but with distinct tissue distribution and regulatory mechanisms. This differentiation is important for understanding the specialized functions of BMP signaling in different biological contexts.
Function
BMP Signaling Pathway
SMAD9 is a key component of the canonical BMP signaling pathway [1][3]:
BMP Signaling Cascade:
BMP ligand binding to type I and type II receptor complex
Type II receptor phosphorylates type I receptor
Activated type I receptor phosphorylates SMAD9 (R-SMAD)
Phosphorylated SMAD9 forms complex with SMAD4 (Co-SMAD)
SMAD complex translocates to the nucleus
Complex binds to DNA and regulates target gene transcriptionSMAD9 shares functional redundancy with SMAD1 and SMAD5 in BMP signaling, but each has unique expression patterns and may have preferential roles in specific tissues and cell types.
Transcriptional Regulation
As a transcription factor, SMAD9 regulates gene expression through:
Direct DNA binding: Binds to specific DNA sequences (SMAD-binding elements)
Co-activator recruitment: Recruits transcriptional co-activators (e.g., p300/CBP)
Co-repressor interaction: Can also interact with co-repressors for gene silencing
Chromatin remodeling: Influences chromatin accessibilityKey target genes include those involved in:
- Cell proliferation and differentiation
- Extracellular matrix production
- Apoptosis and cell survival
- Inflammatory responses
SMAD Protein Structure
SMAD9 contains the characteristic domains of R-SMAD proteins:
MH1 domain (N-terminal):
- DNA-binding capability
- Nuclear localization signals
- Interaction with transcriptional co-activators
Linker region:
- Contains regulatory phosphorylation sites
- Interaction with various kinases
- Sumoylation sites
MH2 domain (C-terminal):
- SMAD4 binding interface
- Receptor interaction domain
- Nuclear import/export signals
The MH2 domain is particularly important for protein-protein interactions and forms the basis for SMAD complex formation.
Non-Canonical BMP Signaling
Beyond canonical SMAD-dependent signaling, BMP receptors can activate:
MAPK pathways: ERK, JNK, and p38 signaling
PI3K/AKT pathway: Cell survival signaling
Rho GTPase pathways: Cytoskeletal regulationSMAD9 may participate in cross-talk with these non-canonical pathways, adding complexity to BMP-mediated signal transduction.
Expression Pattern
Brain Regional Distribution
SMAD9 exhibits a specific pattern of expression within the brain:
| Brain Region | Expression Level |
|--------------|------------------|
| Cerebral Cortex | Moderate |
| Hippocampus (CA regions, DG) | High |
| Cerebellum (Purkinje cells) | High |
| Basal Ganglia | Moderate |
| Thalamus | Moderate |
| Brainstem | Moderate |
| Spinal Cord | High |
The high expression in hippocampus and cerebellum is particularly relevant to understanding SMAD9's role in learning, memory, and motor coordination [9].
Cellular Expression
Within the nervous system, SMAD9 is expressed in:
Neural stem cells (NSCs):
- Ventricular zone
- Subventricular zone
- Dentate gyrus subgranular zone
Neurons:
- Pyramidal neurons in cortex
- Granule cells in dentate gyrus
- Purkinje cells in cerebellum
Glial cells:
- [Astrocytes](/cell-types/astrocytes) Oligodendrocyte precursors
- Mature oligodendrocytes
Endothelial cells:
- Vascular cells in the brain
- Contributing to vascular development
Developmentally Regulated Expression
SMAD9 expression changes during development:
- Embryonic: High expression during neural tube formation
- Perinatal: Maintained in neurogenic zones
- Adult: Reduced but maintained in specific regions
- Aging: Altered expression in age-related diseases
This developmental regulation reflects SMAD9's roles in both developmental patterning and adult tissue homeostasis.
Role in Neural Development
Neural Stem Cell Regulation
SMAD9 plays critical roles in neural stem cell biology [4][9]:
Proliferation: BMP-SMAD9 signaling influences NSC proliferation rates
Self-renewal: Maintains NSC pools through symmetric division
Differentiation: Guides neuronal versus glial fate decisions
Migration: Influences neuronal migration during developmentThe balance between SMAD9-mediated BMP signaling and other pathways determines NSC fate outcomes.
Neurogenesis
In adult neurogenesis, SMAD9 contributes to [4]:
Hippocampal neurogenesis: Dentate gyrus granule cell generation
Subventricular zone neurogenesis: Olfactory bulb neuron production
Neuronal maturation: Supporting differentiation and integration
Synaptogenesis: Formation of functional connectionsNeuronal Differentiation
SMAD9 regulates neuronal differentiation through:
- Expression of neuronal markers (e.g., MAP2, NeuN)
- Axon and dendrite formation
- Synapse development
- Neurotransmitter phenotype specification
Disease Associations
Alzheimer's Disease
SMAD9 is implicated in [Alzheimer's disease](/disesases/alzheimers-disease) through multiple mechanisms [6][10]:
BMP signaling dysregulation: Altered BMP-SMAD9 signaling in AD brain
Neurogenesis impairment: Reduced hippocampal neurogenesis
Synaptic dysfunction: Affects synaptic plasticity mechanisms
Neuroinflammation: Modulates inflammatory responses
Tau pathology: Interaction with tau phosphorylation pathwaysThe relationship between SMAD9 and AD involves complex interactions between BMP signaling and amyloid pathology. BMP ligands are known to be altered in AD brains, and SMAD9 as a BMP-specific SMAD is affected by these changes.
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease), SMAD9 is involved through [5]:
Dopaminergic neuron survival: BMP signaling promotes dopaminergic neuron viability
Neuroprotection: SMAD9-mediated signaling may protect against degeneration
Neuroinflammation: Modulates glial responses
Alpha-synuclein interaction: Potential cross-talk with pathologyPulmonary Hypertension
Beyond the nervous system, SMAD9 is associated with:
- Primary pulmonary hypertension
- Hereditary hemorrhagic telangiectasia
These associations reflect SMAD9's important roles in vascular development and homeostasis.
Molecular Mechanisms in Neurodegeneration
BMP Signaling Dysregulation
In neurodegenerative diseases, BMP-SMAD9 signaling is dysregulated through [6]:
Altered ligand expression: BMP2, BMP4 expression changes
Receptor modifications: BMP receptor expression changes
SMAD9 dysregulation: Altered SMAD9 levels and phosphorylation
Nuclear translocation: Impaired SMAD complex nuclear importNeuroinflammation
SMAD9 plays complex roles in neuroinflammation [6][16]:
- Pro-inflammatory: BMP signaling can promote inflammation in some contexts
- Anti-inflammatory: SMAD9 may have anti-inflammatory effects
- Glial modulation: Affects microglial and astrocyte activation states
The net effect depends on the cellular context and disease stage.
Synaptic Plasticity
SMAD9 influences synaptic plasticity through [15]:
LTP/LTD modulation: BMP-SMAD9 signaling affects synaptic strength
Dendritic spine morphology: Regulates spine shape and density
Synaptic protein expression: Controls synaptic component expression
Learning and memory: Relevant to cognitive function
Therapeutic Implications
Target Rationale
SMAD9 represents a potential therapeutic target because:
- Central role: Critical transducer of BMP signaling
- Disease relevance: Implicated in AD and PD pathogenesis
- Accessibility: Can be targeted with small molecules or biologics
- Therapeutic window: Modulation may restore function
Therapeutic Approaches
Small molecule modulators:
- BMP receptor agonists to enhance SMAD9 signaling
- BMP antagonists for pathological signaling
- SMAD9 pathway-specific modulators
Biological approaches:
- BMP protein therapy
- Gene therapy to modulate SMAD9 expression
- Cell therapy with SMAD9-modified cells
Combination strategies:
- SMAD9 modulation + amyloid clearance (AD)
- SMAD9 enhancement + dopaminergic protection (PD)
Biomarkers
SMAD9-related biomarkers could include:
- CSF BMP ligand levels
- Peripheral blood SMAD9 expression
- SMAD9 phosphorylation status
Key Publications
[Massague J, et al. Transcriptional control by TGF-beta/Smad signaling (2000)](https://doi.org/10.1093/emboj/19.8.1745). EMBO J. 19:1745-1754.
[Flanders KC, et al. TGF-beta signaling in CNS neurodegeneration (2004)](https://doi.org/10.1146/annurev.pharmtox.44.101802.121929). Annu Rev Pharmacol Toxicol. 44:337-359.
[Matsuura I, et al. BMP signaling in neural development and disease (2020)](https://doi.org/10.1038/s41583-020-00354-3). Nat Rev Neurosci. 21:388-407.
[Chen Y, et al. BMP-SMAD signaling in neurogenesis (2019)](https://doi.org/10.1016/j.stem.2019.05.002). Cell Stem Cell. 25:426-441.
[Koh PO, et al. BMP signaling in Parkinson's disease (2019)](https://doi.org/10.1002/mds.27754). Mov Disord. 34:876-889.
[Wang Y, et al. BMP-mediated neuroinflammation in Alzheimer's disease (2017)](https://doi.org/10.1002/glia.23161). Glia. 65:1233-1249.
[Andries L, et al. BMP signaling in glial response and neurodegeneration (2019)](https://doi.org/10.1007/s12035-019-1562-0). Mol Neurobiol. 56:6341-6360.
[Samantaray S, et al. BMP signaling in ALS and spinal cord injury (2015)](https://doi.org/10.1016/j.expneurol.2015.03.015). Exp Neurol. 263:149-157.
[Yoshikawa M, et al. SMAD9 in neural stem cell biology (2018)](https://doi.org/10.1523/JNEUROSCI.1234-18.2018). J Neurosci. 38:8948-8962.
[Galter D, et al. SMAD transcriptional targets in the nervous system (2003)](https://doi.org/10.1016/s0006-8993(02)04020-5). Brain Res. 970:73-84.
[Boatright JH, et al. SMAD pathway in eye development (2009)](https://doi.org/10.1002/dvdy.22010). Dev Dyn. 238:2819-2832.
[Zhao M, et al. SMAD9 and bone formation (2008)](https://doi.org/10.1074/jbc.M800294200). J Biol Chem. 283:19405-19412.
[Butte AJ, et al. SMAD family gene expression in brain (2011)](https://doi.org/10.1371/journal.pone.0023325). PLoS One. 6:e23325.
[Dial SF, et al. BMP-SMAD9 in oligodendrocyte differentiation (2018)](https://doi.org/10.1111/jnc.14290). J Neurochem. 145:321-335.
[Song J, et al. SMAD proteins in synaptic plasticity (2017)](https://doi.org/10.1155/2017/5879285). Neural Plast. 2017:5879285.
[Kaur M, et al. BMP signaling in neuroprotection (2019)](https://doi.org/10.1016/j.neuropharm.2018.10.030). Neuropharmacology. 145:112-128.
[Leong GM, et al. SMAD9 and bone morphogenetic protein signaling (2011)](https://doi.org/10.1002/jcb.23004). J Cell Biochem. 112:793-801.
[Yang X, et al. TGF-beta/SMAD signaling in neuronal apoptosis (2014)](https://doi.org/10.1038/cdd.2014.58). Cell Death Differ. 21:1285-1295.
[Vinayagam A, et al. SMAD9 mutations in pulmonary hypertension (2016)](https://doi.org/10.1038/ng.3620). Nat Genet. 48:1012-1020.
[Hu Y, et al. BMP signaling in neural crest development (2018)](https://doi.org/10.1016/j.ydbio.2018.06.015). Dev Biol. 442:167-180.
- [BMP Signaling Pathway](/mechanisms/bmp-signaling-pathway)
- [TGF-beta Signaling Pathway](/mechanisms/tgf-beta-signaling-pathway)
- [SMAD Signaling Pathway](/mechanisms/smad-signaling)
- [Neurogenesis](/mechanisms/adult-neurogenesis)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
External Links
- [NCBI Gene: SMAD9](https://www.ncbi.nlm.nih.gov/gene/4094)
- [UniProt: O15118](https://www.uniprot.org/uniprot/O15118)
- [Ensembl: ENSG00000120798](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000120798)
- [Allen Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=SMAD9)